
Methotrexate
PRODUCT | Methotrexate inj. |
COMPOSITION | Each ml contains: Methotrexate 25 mg |
INDICATIONS |
Acute lymphocytic leukaemia, prophylaxis of meningeal leukaemia, Non-Hodgkin's lymphomas, osteogenic sarcoma, adjuvant and in advance disease of breast cancer, metastatic or recurrent head and neck cancer, choriocarcinoma and similar trophoblastic diseases, advanced cancer of urinary bladder. |
PACKING TYPE | 2 ml |
MEDICINE TYPE | Allopathic |